Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
The identification of master regulatory genes (MRGs) whose altered expression and activation play a central role in the development of metastatic prostate cancer
EF 2012-13
Résumé
Background: Prostate cancer is the most frequently diagnosed cancer in North American men. While current therapies are able to cure prostate cancer if it is discovered at the early stages, therapies for late-stage prostate cancer (i.e. prostate cancer spread) are only effective for a short term. As such, diagnosis with prostate cancer spread is considered ultimately fatal and an effective therapeutic option is crucially needed. While traditional methods of discovering potentially important changes focus on the most drastic of differences between cancer cells and normal cells, such results are often very noisy and difficult to interpret. The latest advances in computational analysis methods have allowed us to uncover causative changes that are less obvious but potentially more important to prostate cancer spread.
Research Direction: We will use the new computational methods to identify the causative changes that drive prostate cancer spread as potential therapeutic targets through the following three research goals:
1) Using a world-class tumour model that closely resembles patient cases in conjunction with new computational strategies, we will predict the underlying changes that potentially drive prostate cancer spread.
2) We will confirm the predicted changes by evaluating patient tissue samples to ensure the discovery is truly relevant to patients.
3) We will further investigate the underlying biology behind the changes in order to come up with effective treatment options for prostate cancer spread.
Significance: By identifying such driver changes and validating the discovery through further tests, we hope to uncover new and effective therapeutic targets, accordingly develop more effective therapies for treating late-stage prostate cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
280826
Name
Choi Stephen Y
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The identification of master regulatory genes (MRGs) whose altered expression and activation play a central role in the development of metastatic prostate cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Master Regulator; Metastasis; Next-Generation Sequencing; Prostate Cancer; Therapeutic Targets; Xenograft
Abstract
Background: Prostate cancer is the most frequently diagnosed cancer in North American men. While current therapies are able to cure prostate cancer if it is discovered at the early stages, therapies for late-stage prostate cancer (i.e. prostate cancer spread) are only effective for a short term. As such, diagnosis with prostate cancer spread is considered ultimately fatal and an effective therapeutic option is crucially needed. While traditional methods of discovering potentially important changes focus on the most drastic of differences between cancer cells and normal cells, such results are often very noisy and difficult to interpret. The latest advances in computational analysis methods have allowed us to uncover causative changes that are less obvious but potentially more important to prostate cancer spread.
Research Direction: We will use the new computational methods to identify the causative changes that drive prostate cancer spread as potential therapeutic targets through the following three research goals:
1) Using a world-class tumour model that closely resembles patient cases in conjunction with new computational strategies, we will predict the underlying changes that potentially drive prostate cancer spread.
2) We will confirm the predicted changes by evaluating patient tissue samples to ensure the discovery is truly relevant to patients.
3) We will further investigate the underlying biology behind the changes in order to come up with effective treatment options for prostate cancer spread.
Significance: By identifying such driver changes and validating the discovery through further tests, we hope to uncover new and effective therapeutic targets, accordingly develop more effective therapies for treating late-stage prostate cancer.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Choi, Stephen Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~